Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
USRE45313 | NA | Exendin variant peptides |
Jul, 2025
(1 year, 9 months from now) |
Ingredients: LIXISENATIDE
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic